MedTrace Logo

The Effects of Self-management Education Based on Theory of Planned Behavior on Patients With Type 2 Diabetes

NCT02594748 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2016-10-25

No results posted yet for this study

Summary

The aims of the study are as follows:

* To improve self-management intention and behavior of patients with type 2 diabetes (T2 DM).
* To promote patients to make plans for their self-management and gradually integrate the self-management plan into their daily life.
* To improve resilience, well-being, fatigue and quality of life of patients with T2 DM

In order to achieve the aims, we have set the following objectives:

* To develop and apply self-management education program based on the extended theory of planned behavior.
* To evaluate the efficacy of the educational program:

1. Self-management education program delivered face to face (intervention group); (b) standard usual care (comparison group).

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Self-management education

The intervention group will receive diabetes self-management education based on the idea of extended theory of planned behavior .

BEHAVIORAL

Routine care

They will attend the routine lecture in hospital sit and listen, usually 1-2 times during one week in hospital

Sponsors & Collaborators

  • University of Turku

    lead OTHER

Principal Investigators

  • Helena leino-kilpi, PhD · Department of Nursing Science, Universtiy of Turku

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-06-30
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02594748 on ClinicalTrials.gov